Trial Profile
A Randomized, Double-blind, Placebo-Controlled, Ascending Single-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 827 in Healthy Subjects and Subjects With Moderate to Severe Psoriasis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Jan 2020
Price :
$35
*
At a glance
- Drugs Brodalumab (Primary) ; Brodalumab (Primary)
- Indications Plaque psoriasis
- Focus Adverse reactions; First in man; Therapeutic Use
- Sponsors Bausch Health Companies
- 19 Sep 2009 New trial record.